NAT1 polymorphisms and cancer risk: a systematic review and meta-analysis.
about
Predicting radiotherapy response for patients with soft tissue sarcoma by developing a molecular signature.High N-acetyltransferase 1 (NAT1) expression is associated with estrogen receptor expression in breast tumors, but is not under direct regulation by estradiol, 17beta-diol, or dihydrotestosterone in breast cancer cells.
P2860
NAT1 polymorphisms and cancer risk: a systematic review and meta-analysis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
NAT1 polymorphisms and cancer risk: a systematic review and meta-analysis.
@ast
NAT1 polymorphisms and cancer risk: a systematic review and meta-analysis.
@en
type
label
NAT1 polymorphisms and cancer risk: a systematic review and meta-analysis.
@ast
NAT1 polymorphisms and cancer risk: a systematic review and meta-analysis.
@en
prefLabel
NAT1 polymorphisms and cancer risk: a systematic review and meta-analysis.
@ast
NAT1 polymorphisms and cancer risk: a systematic review and meta-analysis.
@en
P2093
P2860
P1476
NAT1 polymorphisms and cancer risk: a systematic review and meta-analysis.
@en
P2093
Chengguang Lin
Jianxin Su
Jianyi Chen
Jinming Ye
Kunyi Zhang
Lijuan Gao
Shaohua Liang
P2860
P304
P577
2015-06-15T00:00:00Z